C

Century Therapeutics

Philadelphia, United States Founded 2018 NASDAQ: IPSC

About

Biotechnology company developing iPSC-derived allogeneic cell therapies for cancer

Company Details

Type
public
Employees
200+
Funding
Public

Key Products

  • CNTY-101
  • CNTY-102
  • CNTY-103
Visit Website

Related Companies